DAFNA Capital Management, LLC

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Stereotaxis, Inc.
STXS
$35.71M16.5513.68M0%+$08.3
2seventy bio, Inc.
TSVT
$6.44M2.341.2M-16.82%-$1.3M1.5
AxoGen, Inc.
AXGN
$7.55M2.14935,8940%+$01.76
KalVista Pharmaceuticals, Inc.
KALV
$9.57M1.91806,973+34.27%+$2.44M2.23
Regulus Therapeutics Inc.
RGLS
$3.08M1.641.07M-3.65%-$116,642.870.72
Century Therapeutics, Inc.
IPSC
$5.46M1.571.31M0%+$01.27
Accuray Incorporated
ARAY
$3.02M1.231.22M0%+$00.7
ProQR Therapeutics N.V.
PRQR
$2.07M1.11905,582-3.72%-$80,146.490.48
Larimar Therapeutics, Inc.
LRMR
$4.98M1.03656,373+102.66%+$2.52M1.16
Alector, Inc.
ALEC
$5.5M0.95912,928+49.68%+$1.82M1.28
Inogen, Inc.
INGN
$1.68M0.89208,790+1,291.93%+$1.56M0.39
Syndax Pharmaceuticals, Inc.
SNDX
$15.7M0.78659,574-11.18%-$1.98M3.65
Day One Biopharmaceuticals, Inc.
DAWN
$11.01M0.76666,463-2.91%-$330,400.012.56
Lineage Cell Therapeutics, Inc.
LCTX
$2.02M0.721.37MNew+$2.02M0.47
Merus N.V.
MRUS
$17.07M0.65378,995-16.68%-$3.42M3.97
Gossamer Bio, Inc.
GOSS
$1.66M0.621.41M-4.53%-$78,812.190.39
IDEAYA Biosciences, Inc.
IDYA
$19.59M0.59446,341-13.56%-$3.07M4.55
AtriCure, Inc.
ATRC
$8.24M0.56271,029+115.91%+$4.43M1.92
Aquestive Therapeutics, Inc.
AQST
$2.13M0.55500,000New+$2.13M0.5
Kura Oncology, Inc.
KURA
$8.8M0.54412,663-16.24%-$1.71M2.05
Perspective Therapeutics, Inc.
CATX
$3.69M0.493.1MNew+$3.69M0.86
Morphic Holding, Inc.
MORF
$8.16M0.46231,7480%+$01.9
Sutro Biopharma, Inc.
STRO
$1.89M0.41334,079+18.02%+$288,149.950.44
Astria Therapeutics, Inc.
ATXS
$3.14M0.41223,265-50.28%-$3.18M0.73
Tandem Diabetes Care, Inc.
TNDM
$9.14M0.4258,208+16.99%+$1.33M2.13
Xenon Pharmaceuticals Inc.
XENE
$11.78M0.36273,739-1.08%-$129,150.002.74
COMPASS Pathways plc
CMPS
$2.02M0.36243,210+26.02%+$417,747.160.47
Cytokinetics, Incorporated
CYTK
$27.91M0.35398,100-0.47%-$133,209.006.49
BioCryst Pharmaceuticals, Inc.
BCRX
$3.6M0.34709,5000%+$00.84
Edgewise Therapeutics, Inc.
EWTX
$5.59M0.33306,197-31.86%-$2.61M1.3
Revolution Medicines, Inc.
RVMD
$16.5M0.31511,8940%+$03.84
Bicycle Therapeutics plc
BCYC
$3.04M0.29122,2000%+$00.71
Stoke Therapeutics, Inc.
STOK
$1.96M0.28145,000New+$1.96M0.46
Arcus Biosciences, Inc.
RCUS
$4.37M0.26231,717-0.43%-$18,880.001.02
ARS Pharmaceuticals, Inc.
SPRY
$2.44M0.25239,194-23.13%-$735,584.600.57
Galapagos NV
GLPG
$4.19M0.2130,1750%+$00.97
Keros Therapeutics, Inc.
KROS
$4.49M0.1967,754-8.88%-$437,383.421.04
Viking Therapeutics, Inc.
VKTX
$15.92M0.18194,117-21.8%-$4.44M3.7
Blueprint Medicines Corporation
BPMC
$10.13M0.17106,763-3.7%-$388,925.992.35
Ascendis Pharma A/S
ASND
$13.98M0.1692,472-25.11%-$4.69M3.25
Immatics N.V.
IMTX
$1.52M0.14145,000+38.09%+$420,400.000.35
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$6.49M0.13118,730-29.65%-$2.74M1.51
PROCEPT BioRobotics Corporation
PRCT
$2.72M0.1154,995-13.12%-$410,433.110.63
Neurocrine Biosciences, Inc.
NBIX
$9.88M0.0771,615-1.38%-$137,920.002.3
Insulet Corporation
PODD
$2.73M0.0215,900New+$2.73M0.63
DexCom, Inc.
DXCM
$9.09M0.0265,552-2.96%-$277,399.992.11
BioNTech SE
BNTX
$1.57M0.0117,000New+$1.57M0.37
BrainsWay Ltd.
BWAY
$1.57M<0.01297,655-3.51%-$57,216.640.37
iShares Biotechnology ETF
IBB
$14.07M<0.01102,5000%+$03.27
SPDR S&P Biotech ETF
XBI
$40.92M<0.01431,215-10.91%-$5.01M9.51